GT Biopharma GTBP
NASDAQ GTBP
$6.10 -0.10 (-1.61%)
At close: Oct 2, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Sales of Property, Plant and Equipment (2022)

Updated

GT Biopharma (GTBP) reported Sales of Property, Plant and Equipment of $1.08 million for Q2 2022, down 69.4% from the prior quarter.

Analysis

GT Biopharma (GTBP) Sales of Property, Plant and Equipment (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 GT Biopharma 8.58 Mn 8.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 1.08 Mn
Mar 31, 2022 3.53 Mn
API Access

GT Biopharma Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=GTBP&period=max&api_key=YOUR_API_KEY